Home  »  Equity Investing   »  BIMI International Medical Inc. (BIMI) stock falls...

BIMI International Medical Inc. (BIMI) stock falls in the aftermarket – Here’s why?

BIMI International Medical Inc. (BIMI) experiences a decline of 43.89% in the aftermarket. However, the last trading session closed at $2.21 with an increase of 225%.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Acquisition of Chongqing Zhuoda Pharmaceutical Co., Ltd.

On 14th September 2021, BIMI announced that it has made a Purchase Agreement to Acquire Chongqing Zhuoda Pharmaceutical Co., Ltd. The acquisition of Zhuoda represents a once-in-a-lifetime possibility for BIMI and the shareholders to broaden the product coverage. The company is convinced that this purchase will add long-term value to the consumers while also promoting the company’s long-term growth.

Moreover, BIMI is enthusiastic about the anticipated acquisition of Zhuoda. Zhuoda has formed long-term strategic partnerships with 14 local hospitals, accounting for the majority of East Chongqing’s grade A tertiary institutions. Last but not least, it will also help BIMI to expand its local market significantly.

Appointment of Chief Financial Officer

BIMI reported the appointment of Amy Xue as the Company’s new Chief Financial Officer on 9th July 2021. Xue is an accomplished senior financial professional with a CPA and ACCA certification. She was CFO of iFresh, Inc. from March 2020 to June 2021 before joining BIMI as Chief Financial Officer.

Moreover, she is the Audit Committee Chairwoman at MingZhu Logistics Holdings Limited since September 2020. She has also worked as the CFO of Goldenbridge Acquisition Ltd. since March 2020. Lastly, Xue was the CFO of XT Energy Group, Inc where she was in charge of the company’s interactions with the Securities and Exchange Commission (SEC), investors, and the preparation of quarterly financial reports.

First Quarter 2021 results

BIMI released the first quarter of 2021 results on 24th May 2021. Revenues were $2.17 million for the three months ended March 31, 2021. However, the revenue climbed by $1.75 million owing mostly to $1.10 million in wholesale pharmaceutical sales and $0.70 million in medical services. Moreover, revenue from the wholesale medical devices division was $0.06 million and $0.25 million, respectively. The drop is mostly due to low demand for medical products in the first quarter.

Not only this but the cost of revenues was $1.58 million and $0.33 million, respectively. Furthermore, BIMI reported an obsolescence loss of $0.03 million on inventories. The drop in inventory availability is due to the expiration of merchandise kept for sale by Dalian’s Boqi pharmacies owing to the COVID-19 pandemic’s lockdown policy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam